228 related articles for article (PubMed ID: 34189859)
1. Estimating the risk of developing secondary hematologic malignancies in patients with T1/T2 prostate cancer undergoing diverse treatment modalities: A large population-based study.
Mo X; Zhou M; Yan H; Chen X; Wang Y
Cancer Med; 2021 Aug; 10(15):5338-5346. PubMed ID: 34189859
[TBL] [Abstract][Full Text] [Related]
2. Secondary Acute Leukemia in Sarcoma Patients: A Population-Based Study.
Sanford NN; Martin AM; Brunner AM; Cote GM; Choy E; DeLaney TF; Aizer AA; Chen YL
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):687-694. PubMed ID: 29413281
[TBL] [Abstract][Full Text] [Related]
3. Risk of Hematologic Malignancies After Radioiodine Treatment of Well-Differentiated Thyroid Cancer.
Molenaar RJ; Sidana S; Radivoyevitch T; Advani AS; Gerds AT; Carraway HE; Angelini D; Kalaycio M; Nazha A; Adelstein DJ; Nasr C; Maciejewski JP; Majhail NS; Sekeres MA; Mukherjee S
J Clin Oncol; 2018 Jun; 36(18):1831-1839. PubMed ID: 29252123
[TBL] [Abstract][Full Text] [Related]
4. Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century.
Pulte D; Jansen L; Brenner H
Blood Cancer J; 2020 May; 10(5):56. PubMed ID: 32404891
[TBL] [Abstract][Full Text] [Related]
5. Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma.
Neugut AI; Ahsan H; Robinson E; Ennis RD
Cancer; 1997 Apr; 79(8):1600-4. PubMed ID: 9118045
[TBL] [Abstract][Full Text] [Related]
6. Maternal smoking and childhood leukemia and lymphoma risk among 1,440,542 Swedish children.
Mucci LA; Granath F; Cnattingius S
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1528-33. PubMed ID: 15342456
[TBL] [Abstract][Full Text] [Related]
7. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.
Moschini M; Zaffuto E; Karakiewicz PI; Andrea DD; Foerster B; Abufaraj M; Soria F; Mattei A; Montorsi F; Briganti A; Shariat SF
Eur Urol; 2019 Feb; 75(2):319-328. PubMed ID: 30293908
[TBL] [Abstract][Full Text] [Related]
8. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
[TBL] [Abstract][Full Text] [Related]
9. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
Nieder AM; Porter MP; Soloway MS
J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
[TBL] [Abstract][Full Text] [Related]
10. Impact of prostate cancer radiotherapy on the biological behavior and specific mortality of subsequent bladder cancer.
Guo X; Liu M; Hou H; Liu S; Zhang X; Zhang Y; Wu P; Pang C; Wang J
Int J Clin Oncol; 2019 Aug; 24(8):957-965. PubMed ID: 30903422
[TBL] [Abstract][Full Text] [Related]
11. Incidence of second malignancies in prostate cancer patients treated with low-dose-rate brachytherapy and radical prostatectomy.
Hamilton SN; Tyldesley S; Hamm J; Jiang WN; Keyes M; Pickles T; Lapointe V; Kahnamelli A; McKenzie M; Miller S; Morris WJ
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):934-41. PubMed ID: 25240272
[TBL] [Abstract][Full Text] [Related]
12. Medical diagnostic X-ray irradiation and risk of leukemia in urban adult population of Poland. II. Bone marrow dose distributions.
Gajewski AK; Rózycki Z; Słowikowska MG; Krzyzanowski M; Majle T
Rocz Panstw Zakl Hig; 1988; 39(5):337-43. PubMed ID: 3247568
[No Abstract] [Full Text] [Related]
13. Myelodysplastic Syndromes and Acute Myeloid Leukemia After Radiotherapy for Prostate Cancer: A Population-Based Study.
Wang R; Zeidan AM; Yu JB; Soulos PR; Davidoff AJ; Gore SD; Huntington SF; Gross CP; Ma X
Prostate; 2017 Apr; 77(5):437-445. PubMed ID: 27868212
[TBL] [Abstract][Full Text] [Related]
14. Leukemia incidence following primary breast carcinoma treatment.
Kaplan HG; Malmgren JA; Atwood M
Cancer; 2004 Oct; 101(7):1529-36. PubMed ID: 15378478
[TBL] [Abstract][Full Text] [Related]
15. External Beam Radiation Therapy With a Brachytherapy Boost Versus Radical Prostatectomy in Gleason Pattern 5 Prostate Cancer: A Population-Based Cohort Study.
Wang C; Kishan AU; Kamrava M; Steinberg ML; King CR
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1045-1052. PubMed ID: 28721887
[TBL] [Abstract][Full Text] [Related]
16. Impact of Advanced External Beam Radiotherapy on Second Haematological Cancer Risk in Prostate Cancer Survivors.
Jahreiß MC; Heemsbergen WD; Janus C; van de Pol M; Dirkx M; Dinmohamed AG; Nout RA; Hoogeman M; Incrocci L; Aben KKH
Clin Oncol (R Coll Radiol); 2023 Apr; 35(4):e278-e288. PubMed ID: 36725405
[TBL] [Abstract][Full Text] [Related]
17. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma.
Chang TW; Weaver AL; Shanafelt TD; Habermann TM; Wriston CC; Cerhan JR; Call TG; Brewer JD
Int J Dermatol; 2017 Nov; 56(11):1125-1129. PubMed ID: 28685851
[TBL] [Abstract][Full Text] [Related]
18. Are biochemical recurrence outcomes similar after radical prostatectomy and radiation therapy? Analysis of prostate cancer-specific mortality by nomogram-predicted risks of biochemical recurrence.
Lee BH; Kibel AS; Ciezki JP; Klein EA; Reddy CA; Yu C; Kattan MW; Stephenson AJ
Eur Urol; 2015 Feb; 67(2):204-9. PubMed ID: 25294696
[TBL] [Abstract][Full Text] [Related]
19. Risk of non-Hodgkin lymphoma after radiotherapy for solid cancers.
Kim CJ; Freedman DM; Curtis RE; Berrington de Gonzalez A; Morton LM
Leuk Lymphoma; 2013 Aug; 54(8):1691-7. PubMed ID: 23193978
[TBL] [Abstract][Full Text] [Related]
20. Why is there so much therapy-related AML and MDS and so little therapy-related CML?
Gale RP; Hlatky L; Sachs RK; Radivoyevitch T
Leuk Res; 2014 Oct; 38(10):1162-4. PubMed ID: 25175829
[No Abstract] [Full Text] [Related]
[Next] [New Search]
